Skip to content
Search

Latest Stories

Shah Rukh Khan’s production venture Darlings starring Alia Bhatt to start rolling soon?

Shah Rukh Khan’s production venture Darlings starring Alia Bhatt to start rolling soon?

By Murtuza Iqbal

From the past few months, there have been reports that Alia Bhatt will be seen in Shah Rukh Khan’s production venture titled Darlings which will also stars Shefali Shah, Vijay Verma, and Roshan Mathew.


Now, according to a report in Pinkvilla, the movie is slated to go on the floors soon in Mumbai. A source told the portal, “It’s set in Mumbai against the backdrop of a middle-class family and traces the lives of two women, as they find courage and love in exceptional circumstances.”

It is said that the film will be officially announced this week. “In fact, the movie is gearing up for a release this year itself. The pre-production work is going on full swing, and the team is all ready to take it on floors very soon in Mumbai,” added the source.

Earlier, Shah Rukh Khan has co-produced Alia’s films like Student Of The Year and Dear Zindagi. In the latter, Alia also got a chance to share screen space with the superstar.

Talking about other films of the actress, Alia has movies like Brahmastra, Gangubai Kathiawadi, and RRR in her kitty. Reportedly, she will also be seen in Karan Johar’s next directorial opposite Ranveer Singh.

Meanwhile, Shah Rukh Khan as a producer has Bob Biswas and Love Hostel lined-up. As an actor, he is currently busy with the shooting of YRF’s Pathan which also stars Deepika Padukone and John Abraham. It is said that after Pathan, the actor will start shooting for Rajkumar Hirani’s next which reportedly features Taapsee Pannu as the female lead.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less